Home
/
ZEVRA THERAPEUTICS, INC.
/
Financials
/
Quarterly
ZEVRA THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ZEVRA THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2016
Mar 31, 2016
$0
May 13, 2016
Q3
2015
Sep 30, 2015
$0
Nov 13, 2015
Q2
2015
Jun 30, 2015
$0
Aug 14, 2015
Q1
2016
Mar 31, 2015
$0
May 13, 2016
Q3
2015
Sep 30, 2014
$0
Nov 13, 2015
Q2
2015
Jun 30, 2014
$0
Aug 14, 2015
Q1
2015
Mar 31, 2014
$0
May 29, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($544.0K)
Nov 5, 2025
Q2
2025
Jun 30, 2025
$74.71M
Aug 12, 2025
Q3
2025
Jun 30, 2025
$74.71M
Nov 5, 2025
Q1
2025
Mar 31, 2025
($3.10M)
May 13, 2025
Q2
2025
Mar 31, 2025
($3.10M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($3.10M)
Nov 5, 2025
Q3
2025
Sep 30, 2024
($33.23M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($19.93M)
Aug 12, 2025
Q3
2025
Jun 30, 2024
($19.93M)
Nov 5, 2025
Q2
2025
Mar 31, 2024
($16.62M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($16.62M)
May 13, 2025
Q3
2025
Mar 31, 2024
($16.62M)
Nov 5, 2025
Q3
2024
Sep 30, 2023
($10.37M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($2.57M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.57M)
Aug 14, 2024
Q3
2024
Mar 31, 2023
($13.22M)
Nov 13, 2024
Q2
2024
Mar 31, 2023
($13.22M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($13.22M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.62M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($24.04M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$4.14M
Nov 5, 2025
Q2
2025
Jun 30, 2025
($71.04M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($5.36M)
May 13, 2025
Q3
2025
Sep 30, 2024
($27.31M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($23.80M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($20.49M)
May 13, 2025
Q3
2024
Sep 30, 2023
($15.36M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($6.25M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($12.83M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.63M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($24.77M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.86M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.22M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
$5.83M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$6.96M
May 12, 2022
Q3
2021
Sep 30, 2020
($1.21M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
$2.59M
Aug 13, 2021
Q1
2021
Mar 31, 2020
($3.78M)
May 14, 2021
Q3
2020
Sep 30, 2019
$3.23M
Oct 30, 2020
Q2
2020
Jun 30, 2019
($7.79M)
Aug 12, 2020